All lobbying filings
Bose Public Affairs Group
Bose Public Affairs Group filed a Q3 report for Association for Prescription Psychedelics on October 20, 2025, reporting $30,000 in lobbying income.
Lobbying for Association for Prescription Psychedelics · Industry association representing pharmaceutical companies
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
New York
Lobbyists on this filing
1
-
DAVID CRANEPreviously held: Senior Policy Advisor, Senate Majority Leader, Senate Republican Leader, Professional Staff, Senate Commerce Committee, Legislative Director, Senator Dan Coats, Legislative Assistant Senator Dan Coats
Government bodies contacted
2
Lobbying activity
1
FDA approval and regulation of prescription psychedelic therapies